logo
  • Company
  • Services
    • Contract manufacturing
    • Contract development
  • Careers
  • Blog
  • Contact
  • ENG
  • EE
  • Company
  • Services
    • Contract manufacturing
    • Contract development
  • Careers
  • Blog
  • Contact
  • ENG
  • EE

Blog

  • Home
  •  
  • Blog
    • SEPTEMBER 22, 2022
    TBD-Biodiscovery became TBD Pharmatech

    TBD-Biodiscovery became TBD Pharmatech

    On 22nd of September we changed our brand name from TBD-Biodiscovery to TBD Pharmatech. The legal name will remain TBD-Biodiscovery Ltd. The change of the name means a new logo with a fresh visual identity…

    Read more
    • haldur
    • Company news
    • MARCH 17, 2023
    TBD Pharmatech at DCAT Week 2023

    TBD Pharmatech at DCAT Week 2023

    March 20-23 2023 TBD Pharmatech will be present at DCAT Week 2023! This is the first time TBD Pharmatech is attending DCAT Week. We are already looking forward to discuss CDMO collaboration! Book a…

    Read more
    • haldur
    • Company news
    • MARCH 15, 2023
    What are inactive pharmaceutical ingredients?

    What are inactive pharmaceutical ingredients?

    Inactive pharmaceutical ingredients (IPIs) are ingredients found in medication that do not directly affect the treatment of a disease or condition. While they may not be active, these components can…

    Read more
    • haldur
    • API & intermediates
    • MARCH 10, 2023
    Project: PET-Diagnostics in collaboration with PharmIdea

    Project: PET-Diagnostics in collaboration with PharmIdea

    TBD Pharmatech worked on a PET-diagnostics project together with Latvian partner SIA PharmIdea from 2017 until 2019. The main objective of the Project was to develop a PET-product used in Positron emission…

    Read more
    • haldur
    • Cooperation projects
    • MARCH 2, 2023
    LIOS and TBD Pharmatech join forces

    LIOS and TBD Pharmatech join forces

    On 21st February 2023, the Latvian Institute of Organic Synthesis (LIOS) and TBD Pharmatech signed the Memorandum of Understanding to strengthen the drug manufacturing performance of the Baltic region….

    Read more
    • haldur
    • Cooperation projects
    • FEBRUARY 28, 2023
    Pharmaceutical compliance

    Pharmaceutical compliance

    Pharmaceutical compliance is a crucial part of the drug development process. It includes the processes and activities undertaken by a pharmaceutical company to ensure that its products meet all the…

    Read more
    • haldur
    • Drugs R&D
    • FEBRUARY 10, 2023
    Maarjavälja career day 2023

    Maarjavälja career day 2023

    On 9th of February the annual Maarjavälja career day 2023 took place. The career day is organized by Faculty of Science and Technology of University of Tartu. The event brings together companies and…

    Read more
    • haldur
    • Company news
  • 1
  • 2
  • 3

Categories

  • API & intermediates
  • Company news
  • Cooperation projects
  • Drugs R&D
  • Pharmaceutical product dossier

Archives

  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022

Tags

Active Pharmaceutical Ingredient career day CMC collaboration CPhI Worldwide Estonian pharmaceutical industry GMP job shadowing pharmaceutical events rebranding students TBD Pharmatech
    TBD Pharmatech (formerly TBD-Biodiscovery) specialises in Active Pharmaceutical Ingredients (API), advanced intermediates, and the development and production of fine chemicals.

    Menu

    • Company
    • Services
      • Contract manufacturing
      • Contract development
    • Careers
    • Blog
    • Contact
    • ENG
    • EE

    Contacts

    • Tiigi 61b, 50410, Tartu, Estonia
    • +372 7477 001
    • info@tbdpharmatech.com
© 2023 osaühing TBD Pharmatech. All rights reservedPrivacy policyTerms and conditionsPowered by Häk